Do people can eat high-quality health products peak health multi-pronged promotion
Release time:
2023-04-12
This year marks the 30th anniversary of Jianfeng Group's listing and the 10th anniversary of Jianfeng Health's establishment. Around this theme, Jianfeng Health has planned its broken Ganoderma lucidum spore powder products, carried out special activities, and successively put advertisements in newspapers, television stations, radio stations and other media. In the newspaper, Jianfeng Health mainly chooses the form of combined publication of hard and soft advertisements. Hard and hard publicity focuses on the thanksgiving feedback activities of broken ganoderma lucidum spore powder. It also sets up corner cutting vouchers to drain offline sales. Soft articles introduce the highlights of products and enterprises. With the help of Jianfeng Group's popularity, they mainly carry out publicity from the aspects of enterprise honor, quality control, product quality, process technology, authentic raw materials, activity publicity, etc. The advertisements put in by the TV station mainly publicize the raw material technology of the products, and let consumers know about the peak health industry and products with the help of the influence of Jianfeng Group. The radio advertisement chose the time with the highest listening rate throughout the day to broadcast the spore powder thanksgiving feedback activities and purchase methods. Through multi-channel advertising, improve the visibility of peak health enterprises and products.
In addition, Peak Health also promoted the main customer groups of spore powder by shooting a short video of the scene to promote it on WeChat. While introducing the products, it also interspersed the introduction of product differences and introduced the Peak Health Experience Hall.
In addition to publicity and promotion, in view of the weak online sales, Jianfeng Health actively seeks online partners this year to carry out online sales, and combines existing products according to functions according to different customer groups. Starting from September
#, Jianfeng Health also launched the "Send Health to the Community on the 30th Anniversary of Jianfeng Group's Listing" activity, organizing employees to go to various communities in Jinhua city to carry out offline activities, introducing the development history and enterprise concept of Jianfeng Health to community residents, and popularizing health knowledge. Let the community residents increase health care knowledge, but also let more consumers understand the business philosophy and product knowledge of peak health.
Recently, Peak Health has also reorganized the existing products and plans to hang the product introduction in the product link of online stores in the form of short videos so that the audience can understand the products more intuitively and accurately. At the same time, Spike Health is also seeking partners to try the live broadcast mode, through the live broadcast to attract the audience, increase communication with customers, thereby increasing customer stickiness.Yin Zhiwu, general manager of Jianfeng Health, said that the purpose of Jianfeng Health's series of publicity and planning is to promote sales, and at the same time, let the people further understand that Jianfeng Health produces and sells high-quality and cost-effective health products that the people can afford and buy, and really benefit the people, pursuing the ideal goal of preventing diseases before they get sick and stopping at the best. (Reporter Ni Yingzhen)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page